AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

NEKTAR THERAPEUTICS Director's Dealing 2014

May 19, 2014

32134_dirs_2014-05-19_23f1934d-e759-45d7-a450-5d3cc2b34af8.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2014-05-19

Reporting Person: Gergel Ivan P. (SVP Drug Development & CMO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct